Plaque Psoriasis
Conditions
Keywords
Psoriasis vulgaris, scalp, topical, applicator, device
Brief summary
This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.
Interventions
DRUGcalcipotriol/betamethasone dipropionate gel in Applicator
Topical treatment of scalp using applicator device. The study as such is non-interventional as the intervention has been decided prior to and independently from the inclusion of the patient in the cohort to be observed.
Sponsors
LEO Pharma
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 years * Dermatologist or general practitioner has decided to initiate treatment with Daivobet® gel Applicator
Exclusion criteria
* Indication not within the approved labelling in France * Contraindication for treatment with calcipotriol or betamethasone dipropionate * Informed consent to participate in the study has not been obtained
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Morisky Medication Adherence Scale-8 | 2 weeks | Degree of adherence to prescribed treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient opinion on Applicator usability | 4 weeks | 5-point Likert scale |
| Patient overall satisfaction | 4 weeks | 4 point Likert scale |
| Patient Global Impression of Improvement | 2 weeks | 7 point Likert scale |
| Investigator's opinion on the properties of the Applicator | Baseline | 5 point rating scale |
Countries
France
Outcome results
None listed